Commercial and business aspects of alpha radioligand therapeutics
Sign Up to like & getrecommendations! Published in 2023 at "Frontiers in Medicine"
DOI: 10.3389/fmed.2022.1070497
Abstract: Radioligand therapy (RLT) is gaining traction as a safe and effective targeted approach for the treatment of many cancer types, reflected by a substantial and growing commercial market (valued at $7.78 billion in 2021, with… read more here.
Keywords: radioligand therapeutics; business aspects; commercial business; radioligand ... See more keywords